Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R AntagonistFebruary 3, 2025
Temu, Shein, and Amazon to be held liable by the EU for dangerous and illegal products they sell, report saysFebruary 3, 2025
Facing “hostile” national abortion landscape, Colorado Democrats plan bills to strengthen state lawsFebruary 3, 2025
Share Twitter Facebook LinkedIn Email Get briefed ahead of your morning calls with the latest UK business headlines, key data and market reactionRead More
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R AntagonistFebruary 3, 2025
No plan to prop up global health, Novo Nordisk Foundation says, as Trump freezes US aidFebruary 3, 2025
By Chloe Meley
